報價延遲最少15分鐘:2024/04/18 02:57 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.5089 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.91/-0.19
|
|
企業價值
32.24M
|
| 資產負債 |
|
每股賬面淨值
0.36
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
530.00K
|
|
每股收益
1.04
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/04/18 02:57 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies. |